View by Specialty

Trending

Drinking more coffee and tea lowers the risk for developng multiple cardiometabolic disorders.
September 17, 2024
3 min read
Save

Drinking moderate amounts of caffeine may cut risk for multiple cardiometabolic diseases

Sarcoma News

SPONSORED CONTENT
Save
SPONSORED CONTENT
October 20, 2022
2 min read
Save

Researchers suggest avoiding excisional biopsies of soft tissue sarcoma of the hand

Researchers suggest avoiding excisional biopsies of soft tissue sarcoma of the hand

BOSTON — Excisional biopsies of soft tissue sarcoma of the hand are associated with more positive margins and a longer time to patients’ first intervention vs. incisional/needle biopsies, results of a study showed.

SPONSORED CONTENT
September 21, 2022
1 min read
Save

FDA approves Pedmark to prevent cisplatin-related ototoxicity among children with cancer

FDA approves Pedmark to prevent cisplatin-related ototoxicity among children with cancer

The FDA approved sodium thiosulfate to reduce risk for cisplatin-associated ototoxicity among certain children with cancer.

Trending

Drinking more coffee and tea lowers the risk for developng multiple cardiometabolic disorders.
September 17, 2024
3 min read
Save

Drinking moderate amounts of caffeine may cut risk for multiple cardiometabolic diseases

SPONSORED CONTENT
September 20, 2022
9 min read
Save

Exercise should be standard part of cancer care during treatment, ASCO guideline states

Exercise should be standard part of cancer care during treatment, ASCO guideline states

It is well known that obesity, physical inactivity and a poor diet increase the risk for various cancer types and contribute to adverse outcomes among adults with certain malignancies.

SPONSORED CONTENT
September 14, 2022
2 min read
Save

Nirogacestat may become standard of care for patients with rare desmoid tumors

Nirogacestat may become standard of care for patients with rare desmoid tumors

Nirogacestat significantly improved PFS compared with placebo among patients with progressing desmoid tumors, according to phase 3 study results presented at ESMO Congress.

SPONSORED CONTENT
September 13, 2022
3 min read
Save

Multicancer blood test shows efficacy for early cancer detection

Multicancer blood test shows efficacy for early cancer detection

A novel multicancer early detection blood test identified a common signal for more than 50 cancer types and predicted where the signal originated in the body among individuals with undiagnosed cancer.

SPONSORED CONTENT
September 11, 2022
1 min read
Save

Sarcoma Foundation of America to honor Crystal L. Mackall, MD

Sarcoma Foundation of America to honor Crystal L. Mackall, MD

Crystal L. Mackall, MD, will receive Sarcoma Foundation of America’s Nobility in Science Award.

SPONSORED CONTENT
September 10, 2022
1 min read
Save

Childhood Cancer Awareness Month: Therapies exhibit efficacy for glioma, sarcoma, lymphoma

Childhood Cancer Awareness Month: Therapies exhibit efficacy for glioma, sarcoma, lymphoma

September is Childhood Cancer Awareness Month.

SPONSORED CONTENT
September 02, 2022
5 min read
Save

Program increases clinician-patient communication, shifts focus to ‘what matters most’

Program increases clinician-patient communication, shifts focus to ‘what matters most’

Despite recommendations in clinical guidelines, a high proportion of patients with advanced cancer do not have appropriate conversations with health care providers about prognosis, treatment options and end-of-life preferences.

SPONSORED CONTENT
August 25, 2022
4 min read
Save

‘Basic’ research leads to potential breakthrough to enhance CAR-T for solid tumors

‘Basic’ research leads to potential breakthrough to enhance CAR-T for solid tumors

Researchers who identified proteins that influence T-cell formation have leveraged their discovery to develop a process that boosts the efficacy of chimeric antigen receptor T-cell therapy for solid tumors.

SPONSORED CONTENT
July 22, 2022
3 min read
Save

Cancer organizations ‘enthusiastically endorse’ Monica M. Bertagnolli, MD, as NCI director

Cancer organizations ‘enthusiastically endorse’ Monica M. Bertagnolli, MD, as NCI director

President Joe Biden has chosen surgical oncologist Monica M. Bertagnolli, MD, FACS, FASCO, to serve as director of the National Cancer Institute, according to published reports.

View more
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails